Actively Recruiting
Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)
Led by SOLTI Breast Cancer Research Group · Updated on 2025-08-06
240
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
Sponsors
S
SOLTI Breast Cancer Research Group
Lead Sponsor
P
Pfizer
Collaborating Sponsor
AI-Summary
What this Trial Is About
HOPE Prostate is an observational study that aims at promoting research against metastatic prostate cancer by means of collective research led by patients (patient-centric trial). Patients with metastatic prostate cancer living in Spain will voluntarily register and fulfil their journey in the study through the study's digital tool. Mainly they are prompted to answer questionnaires about their disease, and to provide a blood sample and an archival tumor biopsy. In HOPE Prostate these samples will be genomically analyzed and every patient case will be presented in a multidisciplinary molecular advisory board (MAB). The MAB will issue a plain report explaining the significance of the results and will try to enumerate future therapeutic options that match patient history and his genomic profile. Finally, patients will have to answer short follow-up questionnaires twice a year for 3 years. The study data will allow us to advance implementing precision medicine to improve the management of current and specially future metastatic prostate cancer patients.
CONDITIONS
Official Title
Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients living in Spain.
- Age 18 years or older.
- Signed informed consent before any screening procedure.
- Metastatic prostate cancer of any subtype confirmed both pathologically and radiologically (stage IV disease).
- Patients about to receive, receiving, or who have completed treatment for metastatic disease with any line of treatment in clinical trial or standard care.
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
You will not qualify if you...
- Inability to consent or conform to the processes involved in a clinical study.
- Presence of a condition or abnormality that, in the opinion of the Investigator, would compromise patient safety or data quality.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
SOLTI Cancer Research Group
Barcelona, Spain, 08008
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here